DIMENSIONAL FUND ADVISORS LP - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 52 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2019. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$9,394,406
-39.0%
341,350
-24.8%
0.00%
-40.0%
Q2 2023$15,392,430
-14.2%
453,634
-9.0%
0.01%
-16.7%
Q1 2023$17,944,783
+80251.0%
498,754
-0.5%
0.01%
-14.3%
Q4 2022$22,333
-99.9%
501,076
-6.3%
0.01%
+16.7%
Q3 2022$15,026,000
-8.9%
534,515
-12.6%
0.01%0.0%
Q2 2022$16,497,000
-18.2%
611,872
+3.3%
0.01%0.0%
Q1 2022$20,176,000
+16.1%
592,358
+31.8%
0.01%
+20.0%
Q4 2021$17,373,000
-10.3%
449,597
+25.4%
0.01%
-16.7%
Q3 2021$19,362,000
+61.1%
358,634
-0.2%
0.01%
+50.0%
Q2 2021$12,020,000
+92.4%
359,424
+18.5%
0.00%
+100.0%
Q1 2021$6,249,000
+15.8%
303,352
-1.5%
0.00%0.0%
Q4 2020$5,395,000
+18.0%
307,915
-0.1%
0.00%0.0%
Q3 2020$4,571,000
+14.6%
308,193
+0.5%
0.00%0.0%
Q2 2020$3,987,000
+594.6%
306,723
-11.3%
0.00%
Q1 2020$574,000
-23.2%
345,916
+3.3%
0.00%
Q4 2019$747,000
+4.8%
334,8560.0%0.00%
Q3 2019$713,000
-20.5%
334,8560.0%0.00%
Q2 2019$897,000
-30.9%
334,856
+26.9%
0.00%
-100.0%
Q1 2019$1,298,000263,8390.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2019
NameSharesValueWeighting ↓
Kynam Capital Management, LP 2,600,000$88,218,00012.13%
Octagon Capital Advisors LP 759,898$25,783,3393.59%
TSP Capital Management Group, LLC 251,895$8,546,8003.08%
ACUTA CAPITAL PARTNERS, LLC 122,343$4,151,0982.81%
5AM Venture Management, LLC 310,270$10,527,4612.62%
COMMODORE CAPITAL LP 631,665$21,432,3932.41%
RTW INVESTMENTS, LP 3,463,201$117,506,4102.24%
Eversept Partners, LP 785,740$26,660,1582.23%
Redmile Group, LLC 1,696,004$57,545,4162.21%
Affinity Asset Advisors, LLC 87,031$2,952,9621.03%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders